GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PPD Inc (NAS:PPD) » Definitions » Net Income (Continuing Operations)

PPD (PPD) Net Income (Continuing Operations) : $370 Mil (TTM As of Sep. 2021)


View and export this data going back to 2020. Start your Free Trial

What is PPD Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. PPD's Net Income (Continuing Operations) for the three months ended in Sep. 2021 was $169 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Sep. 2021 was $370 Mil.


PPD Net Income (Continuing Operations) Historical Data

The historical data trend for PPD's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PPD Net Income (Continuing Operations) Chart

PPD Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20
Net Income (Continuing Operations)
182.85 300.83 106.87 52.76 160.56

PPD Quarterly Data
Dec16 Dec17 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21
Net Income (Continuing Operations) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.10 102.46 47.34 51.46 169.12

PPD Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Sep. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $370 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PPD  (NAS:PPD) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.


PPD Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of PPD's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.


PPD (PPD) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PPD Inc (NAS:PPD) » Definitions » Net Income (Continuing Operations)
Traded in Other Exchanges
N/A
Address
929 North Front Street, Wilmington, NC, USA, 28401
PPD is a global contract research organization that provides clinical trial and laboratory services to pharmaceutical, device, and diagnostic firms. The clinical development services segment offers outsourced trial services, spanning early- and late-stage trials, as well as peri- and post-approval trials, and the laboratory services segment includes both advanced lab testing and central lab services. The company was taken private in 2011 and went public again in 2020.. Thermo Fisher Scientific announced it will acquire PPD for $17.4 billion, which is scheduled to close by the end of 2021.
Executives
H&f Corporate Investors Viii, Ltd. 10 percent owner 415 MISSION STREET, SUITE 5700, SAN FRANCISCO CA 94105
H&f Corporate Investors Vii, Ltd. 10 percent owner 415 MISSION STREET, SUITE 5700, SAN FRANCISCO CA 94105
David Michael Johnston officer: See Remarks C/O PPD, INC. 929 NORTH FRONT STREET WILMINGTON NC 28401
David S Simmons director, officer: Chief Executive Officer PFIZER INC. ATTN. CORP. SECRETARY, 235 EAST 42ND STREET, NEW YORK NY 10017
Glen Donovan officer: Chief Accounting Officer C/O PPD, INC. 929 NORTH FRONT STREET WILMINGTON NC 28401
Ronald E Garrow officer: See Remarks 2000 PURCHASE STREET, PURCHASE NY 10577
Karen Kaucic officer: See Remarks C/O PPD, INC. 929 NORTH FRONT STREET WILMINGTON NC 28401
Judd Hartman officer: See Remarks 3124 DEVER COURT WILMINGTON NC 28411
Jill Pellegrino officer: SVP & General Manager of AES C/O PPD, INC. 929 NORTH FRONT STREET WILMINGTON NC 28401
H&f Executives Vii, L.p. 10 percent owner ONE MARITIME PLAZA 12TH FLOOR SAN FRANCISCO CA 94111
Hellman & Friedman Investors Viii, L.p. 10 percent owner 415 MISSION STREET, SUITE 5700, SAN FRANCISCO CA 94105
P. Hunter Philbrick director C/O HELLMAN & FRIEDMAN INVESTORS, ONE MARTIME PLAZA, 12TH FLOOR, SAN FRANCISCO CA 94111
Carlyle Partners Vi Holdings Ii, L.p. 10 percent owner C/O THE CARLYLE GROUP, SUITE 220 SOUTH 1001 PENNSYLVANIA AVENUE, N.W. WASHINGTON DC 20004
Tc Group Vi, L.l.c. 10 percent owner C/O THE CARLYLE GROUP, SUITE 220 SOUTH, 1001 PENNSYLVANIA ANVENE, N.W., WASHINGTON DC 20004
Tc Group Vi, L.p. 10 percent owner C/O THE CARLYLE GROUP, SUITE 220 SOUTH, 1001 PENNSYLVANIA AVENUE, N.W., WASHINGTON DC 20004